The Triple Negative Breast Cancer Foundation has partnered with PRIME Education, a leading research and continuing medical education provider, to offer accredited courses to TNBC healthcare professionals.
PRIME Education - TNBC Programs
Emerging Evidence in Triple Negative Breast Cancer (1-hour CME/CE Credit)
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options and a poor prognosis. New and emerging agents, including antibody-drug conjugates, are poised to fulfill an unmet need for patients with TNBC. In this program, two leading TNBC experts will discuss:
- Current, new, and emerging therapies for TNBC
- Managing adverse events associated with treatments
- Evidence-based treatment decision-making for patients with advanced/metastatic disease
Transforming TNBC Care in Community Oncology Practices (1-hour CME/CE Credit)
Rapidly evolving evidence in triple negative breast cancer (TNBC) can present challenges in aligning practice with the latest clinical data and guideline recommendations. In this expert-led video activity, participants will review insights from a recent TNBC quality improvement initiative conducted at community oncology practices nationwide, and evaluate the latest clinical evidence and patient management approaches in TNBC to enhance patient-centered care.
Participants will also be able to download two point-of-care tools focused on evidence-based treatment decision-making and adverse event management to support quality patient care.
Watch this video to gain insight on real-world practice patterns in TNBC care and align your practice with the latest guideline recommendations.